Overview
LNAI market data
Price History
LNAI price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for LNAI. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
8-K filing — Lunai Bioworks Inc. (LNAI)SEC EDGAR · Jun 17, 2026, 8:32 PM
Lunai Bioworks Regains Nasdaq ComplianceBenzinga · Jun 16, 2026, 8:10 PM
Lunai Bioworks' BioSymetrics And BrainStorm Therapeutics Announce Strategic Collaboration And LOI Integrating AI Discovery, Human Brain Organoid Modeling, And In Vivo Validation To Generate Differentiated Neurology Assets For Pharmaceutical Partnering And DevelopmentBenzinga · May 28, 2026, 1:25 PM
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption TimesBenzinga · May 22, 2026, 1:50 PM
Federal Judge Granted Lunai Bioworks Permission On May 20 To Conduct Expedited Third-Party Discovery To Identify Naked Short Sellers Of Lunai Common Stock Through 2025-2026Benzinga · May 22, 2026, 1:30 PM
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News PendingBenzinga · May 21, 2026, 11:55 PM
Lunai Bioworks Announces 1-For-8 Reverse Stock Split Effective May 22Benzinga · May 20, 2026, 1:25 PM
Lunai Bioworks Inc. - Common Stock Q3 EPS $(0.10), Sales $20.942KBenzinga · May 15, 2026, 10:19 PM
Lunai Bioworks Approves Reverse Stock Split At Ratio Of 1-For-3 To 1-For-30Benzinga · May 13, 2026, 8:53 PM
8-K/A filing — Lunai Bioworks Inc. (LNAI)SEC EDGAR · May 11, 2026, 9:30 PM